Exagen Inc.
XGN- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001274737
In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Exagen Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 33 | 41 | +8 |
| Shares | 6.38M | 6.11M | −269.0K (−4.2%) |
| Value | $19.7M | $25.1M | +$5.34M (+27.1%) |
New holders (10)
Institutions that held Exagen Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Toronto Dominion Bank | 891,366 | $3.65M | 0.01% |
| Driehaus Capital Management LLC | 418,505 | $1.72M | 0.01% |
| Huntleigh Advisors, Inc. | 71,169 | $291.8K | 0.06% |
| Marshall Wace, LLP | 16,048 | $65.8K | 0.00% |
| Virtu Financial LLC | 11,203 | $46.0K | 0.00% |
| CI Private Wealth, LLC | 11,093 | $45.5K | 0.00% |
| Citigroup Inc | 5,582 | $22.9K | 0.00% |
| SBI Securities Co., Ltd. | 5,050 | $20.7K | 0.00% |
| Royal Bank of Canada | 335 | $1.00K | 0.00% |
| BNP Paribas Arbitrage, SA | 29 | $119 | 0.00% |
Sold out (2)
Institutions that held Exagen Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Cowen and Company, LLC | 891,366 | $2.75M |
| First Bank & Trust | 13,518 | $41.8K |